Komori
Occurring Fact4569KYORIN Pharmaceutical Co.,Ltd.Pharmaceuticals

Notice Regarding a Change in Major Shareholders

Copernic Global Investors LLC’s percentage of voting rights held increased from 9.04% as of 30 April 2026 to 10.44% as of 15 October 2026, resulting in a change in major shareholders.

Worth reading
35Immaterial
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
1.4
Increase in voting rights stake (percentage points)
Wording
Conditional
How definitive the wording is.

Changes in major shareholders

Subject Entity

KYORIN Pharmaceutical Co.,Ltd., Copernic Global Investors LLC

Occurrence15 October 2026
12 days later
Awareness or receipt of notice27 October 2026 (the Company confirmed the change upon the filing of a Large Shareholding Report (Change Report))
This disclosure10/28/2026
Cause

The Company confirmed the change in major shareholders following the filing of a Large Shareholding Report (Change Report) by Copernic Global Investors LLC with the Kanto Local Finance Bureau on 27 October 2026.

Change in voting rights ownership ratio

Shareholders Covered9.04%→10.44%(+1.40pt)

The voting rights ownership percentage is the proportion of the voting rights exercisable at a shareholders' meeting held by the shareholder.

Voting rights ownership percentage before the change

52,428 units (5,242,800 shares), 9.04% (as of 30 April 2026)

Voting rights ownership percentage after the change

60,512 units (6,051,200 shares), 10.44% (as of 15 October 2026)

Impact on Earnings Forecast

This matter is based on the submission of a Large Shareholding Report (Amendment Report), and there are no matters requiring specific disclosure regarding the outlook at this time.

Related procedures

Court or authority

Kanto Local Finance Bureau

Outlook

This matter is based on the submission of a Large Shareholding Report (Amendment Report), and there are no matters requiring specific disclosure regarding the outlook at this time.

Event that occurred
ItemDetails
Event nameChanges in major shareholders
Date of occurrence15 October 2026
Date recognized / date notice received27 October 2026 (the Company confirmed the change upon the filing of a Large Shareholding Report (Change Report))
Subject EntityKYORIN Pharmaceutical Co.,Ltd., Copernic Global Investors LLC
CauseThe Company confirmed the change in major shareholders following the filing of a Large Shareholding Report (Change Report) by Copernic Global Investors LLC with the Kanto Local Finance Bureau on 27 October 2026.
Impact on Earnings ForecastThis matter is based on the submission of a Large Shareholding Report (Amendment Report), and there are no matters requiring specific disclosure regarding the outlook at this time.
Court or authorityKanto Local Finance Bureau
Voting rights ownership percentage before the change52,428 units (5,242,800 shares), 9.04% (as of 30 April 2026)
Voting rights ownership percentage after the change60,512 units (6,051,200 shares), 10.44% (as of 15 October 2026)
OutlookThis matter is based on the submission of a Large Shareholding Report (Amendment Report), and there are no matters requiring specific disclosure regarding the outlook at this time.
Items this document does not state (15)
Target Locations / ProductsAmount of Impact on Business PerformanceAccounting period in which recognizedType of litigation or proceedingPlaintiffDefendantDate of filing / date of actionClaim amount / surcharge amountAmount of receivables at risk of non-collection or delayed collectionSuspended operationsScheduled resumption dateInvestigation structureMeasures to prevent recurrenceDirectors' and officers' liabilityPlanned follow-up disclosure

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The Company confirmed the change in major shareholders following the filing of a Large Shareholding Report (Change Report) by the shareholder with the Kanto Local Finance Bureau on 27 October 2026.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding a Change in Major Shareholders | KYORIN Pharmaceutical Co.,Ltd. (4569) timely disclosure | Komori